Hospitalizations Due to Unstable Angina Pectoris in Diastolic and Systolic Heart Failure

American Journal of Cardiology

Volumn 99, Issue 4, 2007, Pages 460-464

  Ahmed, Ali ^a   Zile, Michael R ^b   Rich, Michael W ^c   Fleg, Jerome L ^d   Adams Jr , Kirkwood F ^e   Love, Thomas E ^f   Young, James B ^g   Aronow, Wilbert S ^h   Kitzman, Dalane W ⁱ   Gheorghiade, Mihai ^j   Dell'Italia, Louis J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h NEW YORK MEDICAL COLLEGE   (United States)

ⁱ WAKE FOREST UNIVERSITY   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMBULATORY CARE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC HEART FAILURE; FEMALE; FOLLOW UP; HAZARD RATIO; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTOLIC HEART FAILURE; UNSTABLE ANGINA PECTORIS; VALVULAR HEART DISEASE;

AGED; ANGINA, UNSTABLE; DIASTOLE; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SYSTOLE;

EID: 33751377832     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.08.056     Document Type: Article

References (26)

1. Mosseri M., Yarom R., Gotsman M.S., and Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 74 (1986) 964-972
2. Brush Jr. J.E., Cannon III R.O., Schenke W.H., Bonow R.O., Leon M.B., Maron B.J., and Epstein S.E. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 319 (1988) 1302-1307
3. Iriarte M., Caso R., Murga N., Faus J.M., Sagastagoitia D., Molinero E., Lopez de Argumedo M., and Boveda J. Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy. Am J Cardiol 75 (1995) 335-339
4. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., and Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 (1999) 1948-1955
5. Auerbach M.A., Schoder H., Hoh C., Gambhir S.S., Yaghoubi S., Sayre J.W., Silverman D., Phelps M.E., Schelbert H.R., and Czernin J. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 99 (1999) 2921-2926
6. Ahmed A., Roseman J.M., Duxbury A.S., Allman R.M., and DeLong J.F. Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure. Am Heart J 144 (2002) 365-372
7. Ahmed A. Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failure. J Gerontol A Biol Sci Med Sci 60 (2005) 1339-1344
8. Al-Mohammad A., Mahy I.R., Norton M.Y., Hillis G., Patel J.C., Mikecz P., and Walton S. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles. Heart 80 (1998) 559-564
9. Schinkel A.F., Bax J.J., Boersma E., Elhendy A., Roelandt J.R., and Poldermans D. How many patients with ischemic cardiomyopathy exhibit viable myocardium?. Am J Cardiol 88 (2001) 561-564
10. The Digitalis Investigation Group. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Control Clin Trials 17 (1996) 77-97
11. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
12. Psaty B.M., Koepsell T.D., Wagner E.H., LoGerfo J.P., and Inui T.S. Beta blockers and the primary prevention of nonfatal myocardial infarction in patients with high blood pressure. Am J Cardiol 66 suppl (1990) 12G-14G
13. Held P. Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects. Am J Cardiol 71 suppl (1993) 39C-44C
14. The Digitalis Investigation Group. Protocol: Trial to Evaluate the Effect of Digitalis on Mortality in Heart Failure (1991), National Heart, Lung, and Blood Institute, Bethesda, MD 1-36
15. SPSS for Windows, Release 14 (2006), SPSS, Chicago, IL
16. Marcus M.L., Koyanagi S., Harrison D.G., Doty D.B., Hiratzka L.F., and Eastham C.L. Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy. Am J Med 75 (1983) 62-66
17. Isoyama S. Interplay of hypertrophy and myocardial ischemia. In: Lorell B.H., and Grossman W. (Eds). Diastolic Relaxation of the Heart (1992), Kluwer Academic Publishers, Boston 203-211
18. Iriarte M., Murga N., Sagastagoitia D., Molinero E., Morillas M., Salcedo A., Estella P., and Etxebeste J. Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension. Am J Cardiol 71 (1993) 308-312
19. Strauer B.E. Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure. Am J Cardiol 65 suppl (1990) 34G-41G
20. Tomanek R.J., Wessel T.J., and Harrison D.G. Capillary growth and geometry during long-term hypertension and myocardial hypertrophy in dogs. Am J Physiol 261 suppl (1991) H1011-H1018
21. Nijland F., Kamp O., Verhorst P.M., de Voogt W.G., and Visser C.A. In-hospital and long-term prognostic value of viable myocardium detected by dobutamine echocardiography early after acute myocardial infarction and its relation to indicators of left ventricular systolic dysfunction. Am J Cardiol 88 (2001) 949-955
22. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
23. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
24. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., Palensky J., Wittes J., and Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341 (1999) 709-717
25. Pitt B., Poole-Wilson P.A., Segal R., Martinez F.A., Dickstein K., Camm A.J., Konstam M.A., Riegger G., Klinger G.H., Neaton J., Sharma D., and Thiyagarajan B. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 355 (2000) 1582-1587
26. Gottdiener J.S., McClelland R.L., Marshall R., Shemanski L., Furberg C.D., Kitzman D.W., Cushman M., Polak J., Gardin J.M., Gersh B.J., Aurigemma G.P., and Manolio T.A. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 137 (2002) 631-639